Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Establishes Manufacturing Facility in Singapore

NEW YORK (GenomeWeb News) – Life Technologies today announced it has created a Global Instrument Center of Excellence in Singapore, making it the company's only internal instrument manufacturing facility outside the US.

The design and manufacturing of Life Tech's products — including its next-generation sequencers and molecular diagnostic instruments — for its customers within the region and outside of Asia-Pacific will be conducted at the new center, the Carlsbad, Calif.-based firm said.

The manufacture of Ion Torrent's Personal Genome Machine will also be moved to the Singapore center, a Life Tech spokesperson told GenomeWeb Daily News. The company has not made any announcements concerning the Ion Proton sequencer, she added.

Asia-Pacific is a key growth driver for the life science industry, and Life Tech said that its sales in the area, excluding Japan, grew more than 9 percent in 2011, while the volume of items shipped per day in the region has increased four-fold. The Asia-Pacific region is about 10 percent of Life Tech's total business, the spokesperson said.

Life Tech's presence in Asia has consisted of commercial offices in Singapore as well as India, Korea, and Australia, and dedicated distribution centers in Singapore, India, Australia, New Zealand, and Korea. Life Tech also conducts research in India.

"The scientific community in Asia Pacific is growing at a rapid rate," Mark
Smedley, President of Asia Pacific and Japan for Life Technologies, said in a statement. "By establishing the Instrument Center of Excellence in Singapore we are providing our global customers innovative technologies more efficiently, while helping them advance their research even faster."

Kevin Lai, director of the Biomedical Sciences Group for the Singapore Economic Development Board, added "This new Global Instrument Center of Excellence is an example of how leading life science instrumentation companies are increasingly looking to Singapore as an integrated location for complex analytical instrument manufacturing, research and development of next generation platforms, and Regional Headquarters for Asia."

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.